Literature DB >> 7522386

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

E Braak1, H Braak, E M Mandelkow.   

Abstract

Frontal sections of the temporal lobe including the transentorhinal/entorhinal region, amygdala, and/or hippocampus from human adult brains are studied for cytoskeleton changes using immunostaining with the antibodies AT8 and Alz-50 and selective silver impregnation methods for neurofibrillary changes of the Alzheimer type. For the purpose of correlation, the two methods are carried out one after the other on the same section. Layer pre-alpha in the transentorhinal/entorhinal region harbours nerve cells which are among the first nerve cells in the entire brain to show the development of neurofibrillary changes. This presents the opportunity for study of both early events in the destruction of the cytoskeleton in individual neurons, and to relate changes which occur in the neuronal processes in the absence of alterations in their immediate surroundings to those happening in the soma. Immunoreactions with the AT8 antibody in particular reveal a clear sequence of changes in the neuronal cytoskeleton. Group 1 neurons present initial cytoskeleton changes in that the soma, dendrites, and axon are completely marked by granular AT8 immunoreactive material. These neurons appear quite normal and turn out to be devoid of argyrophilic material when observed in silver-stained sections. Group 2 neurons show changes in the cellular processes. The terminal tuft of the apical dendrite is replaced by tortuous varicose fibres and coarse granules. The distal portions of the dendrites are curved and show appendages and thickened portions. Intensely homogeneously immunostained rod-like inclusions are encountered in these thickened portions and in the soma. A number of these rod-like inclusions are visible after silver staining, as well. Group 3 neurons display even more pronounced alterations of their distal--most dendritic portions. The intermediate dendritic parts lose immunoreactivity, but the soma is homogeneously immunostained. Silver staining reveals in most of the distal dendritic parts neuropil threads, and in the soma a classic neurofibrillary tangle. Group 4 structures are marked by accumulations of coarse AT8-immunoreactive granules. Silver staining provides evidence that the fibrillary material has become an extraneuronal, "early" ghost tangle. Finally, group 5 structures present "late" ghost tangles in silver-stained sections but fail to demonstrate AT8 immunoreactivity. It is suggested that the altered tau protein shown by the antibody AT8 represents an early cytoskeleton change which eventually leads to the formation of argyrophilic neurofibrillary tangles and neuropil threads.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522386     DOI: 10.1007/bf00293315

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  57 in total

1.  Mapping of the Alz 50 epitope in microtubule-associated proteins tau.

Authors:  H Ksiezak-Reding; C H Chien; V M Lee; S H Yen
Journal:  J Neurosci Res       Date:  1990-03       Impact factor: 4.164

2.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

3.  [Do the island neurons of regio entorhinalis belong to the class of pyramid or star-shaped cells?].

Authors:  H Braak; E Braak; H Strenge
Journal:  Z Mikrosk Anat Forsch       Date:  1976

4.  Alz-50 recognizes a phosphorylated epitope of tau protein.

Authors:  K Uéda; E Masliah; T Saitoh; S L Bakalis; H Scoble; K S Kosik
Journal:  J Neurosci       Date:  1990-10       Impact factor: 6.167

5.  Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location.

Authors:  G I Szendrei; V M Lee; L Otvos
Journal:  J Neurosci Res       Date:  1993-02-01       Impact factor: 4.164

6.  Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filaments.

Authors:  C B Caputo; C Wischik; M Novak; C W Scott; W F Brunner; E M De Garcini; M M Lo; T E Norris; A I Salama
Journal:  Neurobiol Aging       Date:  1992 Mar-Apr       Impact factor: 4.673

7.  Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals.

Authors:  D L Sparks; H Liu; S W Scheff; C M Coyne; J C Hunsaker
Journal:  J Neuropathol Exp Neurol       Date:  1993-03       Impact factor: 3.685

8.  Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region.

Authors:  A Probst; V Basler; B Bron; J Ulrich
Journal:  Brain Res       Date:  1983-06-06       Impact factor: 3.252

9.  Casein kinase II alteration precedes tau accumulation in tangle formation.

Authors:  E Masliah; D S Iimoto; M Mallory; T Albright; L Hansen; T Saitoh
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more
  181 in total

1.  Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.

Authors:  M E King; N Ghoshal; J S Wall; L I Binder; H Ksiezak-Reding
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.

Authors:  Sabine Ott; Andreas Wolfram Henkel; Maria Kerstin Henkel; Zoran B Redzic; Johannes Kornhuber; Jens Wiltfang
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

4.  Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration.

Authors:  Tomasz Jaworski; Benoit Lechat; David Demedts; Lies Gielis; Herman Devijver; Peter Borghgraef; Hans Duimel; Fons Verheyen; Sebastian Kügler; Fred Van Leuven
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

5.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.

Authors:  M K Ahlijanian; N X Barrezueta; R D Williams; A Jakowski; K P Kowsz; S McCarthy; T Coskran; A Carlo; P A Seymour; J E Burkhardt; R B Nelson; J D McNeish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

8.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Stratum radiatum of CA2 is an additional target of the perforant path in humans and monkeys.

Authors:  Song-Lin Ding; Suzanne N Haber; Gary W Van Hoesen
Journal:  Neuroreport       Date:  2010-03-10       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.